BlackRock Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $4.94M | Buy |
373,148
+65,671
| +21% | +$870K | 0.01% | 1602 |
|
|
2016
Q3 | $7.29M | Buy |
307,477
+3,686
| +1% | +$87.4K | 0.01% | 1226 |
|
|
2016
Q2 | $8.76M | Buy |
303,791
+25,698
| +9% | +$741K | 0.01% | 1043 |
|
|
2016
Q1 | $8.91M | Buy |
278,093
+7,770
| +3% | +$249K | 0.01% | 996 |
|
|
2015
Q4 | $11.6M | Buy |
270,323
+1,313
| +0.5% | +$56.1K | 0.01% | 853 |
|
|
2015
Q3 | $9.47M | Sell |
269,010
-4,145
| -2% | -$146K | 0.01% | 959 |
|
|
2015
Q2 | $12.5M | Buy |
273,155
+20,954
| +8% | +$962K | 0.02% | 858 |
|
|
2015
Q1 | $11.8M | Buy |
252,201
+2,716
| +1% | +$127K | 0.02% | 845 |
|
|
2014
Q4 | $7.9M | Sell |
249,485
-1,939
| -0.8% | -$61.4K | 0.01% | 1085 |
|
|
2014
Q3 | $5.96M | Buy |
251,424
+2,053
| +0.8% | +$48.7K | 0.01% | 1220 |
|
|
2014
Q2 | $7.48M | Sell |
249,371
-19,820
| -7% | -$594K | 0.01% | 1142 |
|
|
2014
Q1 | $7.11M | Buy |
269,191
+2,957
| +1% | +$78.1K | 0.01% | 1124 |
|
|
2013
Q4 | $6.69M | Sell |
266,234
-5,329
| -2% | -$134K | 0.01% | 1149 |
|
|
2013
Q3 | $5.56M | Buy |
271,563
+1,682
| +0.6% | +$34.4K | 0.01% | 1208 |
|
|
2013
Q2 | $5.38M | Buy |
+269,881
| New | +$5.38M | 0.01% | 1162 |
|